Nondialytic management of hyperkalemia and pulmonary edema among end-stage renal disease patients: An evaluation of the evidence

Seminars in Dialysis

Volumn 17, Issue 1, 2004, Pages 22-29

  Evans, Kimberley ^a   Reddan, Donal N ^a   Szczech, Lynda Anne ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BICARBONATE; CALCIUM CHLORIDE; CAPTOPRIL; CATECHOLAMINE; CATION EXCHANGE RESIN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; GLUCONATE CALCIUM; GLUCOSE; GLYCERYL TRINITRATE; INSULIN; LOOP DIURETIC AGENT; MORPHINE SULFATE; NITRATE; NITROPRUSSIDE SODIUM; POTASSIUM; SALBUTAMOL; SORBITOL;

CLINICAL FEATURE; CLINICAL TRIAL; DIALYSIS; DIGITALIS INTOXICATION; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DRUG MECHANISM; DRUG TOXICITY; DYSPNEA; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERKALEMIA; HYPERNATREMIA; HYPERTENSION; HYPERVOLEMIA; HYPOGLYCEMIA; INTESTINE NECROSIS; KIDNEY FAILURE; LUNG EDEMA; MUSCLE WEAKNESS; OXYGENATION; P WAVE; POSITIVE END EXPIRATORY PRESSURE; POTASSIUM BLOOD LEVEL; QRS COMPLEX; REVIEW; SIDE EFFECT; T WAVE; TACHYCARDIA; TREATMENT OUTCOME; TREMOR;

EID: 1642348571     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2004.17110.x     Document Type: Review

References (83)

1. Sacchetti A, Stuccio N, Panebianco P, Torres M: ED hemodialysis for treatment of renal failure emergencies. Am J Emerg Med 17:305-307, 1999
2. Sacchetti A, Harris R, Patel K: Emergency department and presentation of renal dialysis patients: indications for EMS transport directly to dialysis centers. J Emerg Med 9:141-144, 1991
3. Surawicz B: Relationship between electrocardiogram and electrolytes. Am Heart J 73:814-834, 1967
4. Surawicz B, Chlebus H, Mazzoleni A: Hemodynamic and electrocardiographic effects of hyperpotassemia. Differences in response to slow and rapid increases in concentration of plasma K. Am Heart J 73:647-664, 1967
5. Ettinger P, Regan T, Oldewurtel H: Hyperkalemia, cardiac conduction, and the electrocardiogram: a review. Am Heart J 88:360-371, 1974
6. Acker C, Johnson J, Palevsky P, Greenberg A: Hyperkalemia in hospitalized patients: causes, adequacy of treatment and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med 158:917-924, 1998
7. Szerlip H, Weiss J, Singer I: Profound hyperkalemia without electrocardiographic manifestations. Am J Kidney Dis 7:461-465, 1986
8. Greenberg A: Hyperkalemia: treatment options. Semin Nephrol 18:46-57, 1998
9. Allon M: Treatment and prevention of hyperkalemia in end stage renal disease. Kidney Int 43:1197-1209, 1993
10. Rose B, Post T: Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed. New York: McGraw-Hill, 2001
11. Dittrich K, Walls R: Hyperkalemia: ECG manifestations and clinical considerations. J Emerg Med 4:449-455, 1986
12. Bower J, Mengle H: The additive effects of digitalis. A warning with report of two deaths. JAMA 106:1151-1153, 1936
13. Fenton F, Smally A, Laut J: Hyperkalemia and digoxin toxicity in a patient with kidney failure. Ann Emerg Med 28:440-441, 1996
14. Nola G, Pope S, Harrison D: Assessment of the synergistic relationship between serum calcium and digitalis. Am Heart J 79:499-507, 1970
15. Bremer BM, Levine SA: Brenner & Rector's, the Kidney, 6th ed. Philadelphia: WB Saunders, 2000
16. Ferrannini E, Taddei S, Santoro D, Natali A, Boni C, Del Chiaro D, Buzzigoli G: Independent stimulation of glucose metabolism and Na+ K+ exchange by insulin in the human forearm. Am J Physiol 255:E953-E958, 1988
17. Alvestrand A, Wahren J, Smith D, Defronzo R: Insulin-mediated potassium uptake is normal in uremic and healthy subjects. Am J Physiol 246:E174-E180, 1984
18. Allon M: Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol. Am J Kidney Dis 28:508-514, 1996
19. Ngugi N, McLigeyo S, Kayima J: Treatment of hyperkalemia by altering the transcellular gradient in patients with renal failure: efficacy of various therapeutic approaches. East Afr Med J 74:503-509, 1997
20. Kim H: Combined effects of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease. Nephron 72:476-482, 1996
21. Blumberg A, Weidmann P, Shaw S, Gnadinger M: Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med 85:507-512, 1988
22. Goldfarb S, Cox M, Singer I, Goldberg M: Acute hyperkalemia induced by hyperglycemia: hormonal mechanisms. Ann Intern Med 84:426-432, 1976
23. Montoliu J, Revert L: Lethal hyperkalemia associated with severe hyperglycemia in diabetic patients with renal failure. Am J Kidney Dis 5:47-48, 1985
24. Allon M, Copkney C: Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney Int 38:869-872, 1990
25. Lens X, Montoliu J, Cases A, Campistol J, Revertt L: Treatment of hyperkalemia in renal failure: salbutamol v. insulin. Nephrol Dial Transplant 4:228-232, 1989
26. Liou H, Chiang S, Wu S, Huang T, Campese V, Smogorzewski M, Yang W: Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure. Am J Kidney Dis 23:266-271, 1994
27. Allon M, Dunlay R, Copkney C: Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Ann Intern Med 110:426-429, 1989
28. Allon M, Shanklin N: Effect of albuterol treatment on subsequent dialytic potassium removal. Am J Kidney Dis 26:607-613, 1995
29. Mandelberg A, Krupnik Z, Houri S, Smetana S, Giald E, Matas Z, Priel I: Salbutamol metered dose inhaler with spacer for hyperkalemia. Chest 115:617-622, 1999
30. Mocan M, Mocan G, Mocan H, Gorcin B: Inhaler salbutamol for acute hyperkalemia. Israel J Med Sci 29:39-41, 1993
31. Montoliu J, Lens X, Revert L: Potassium-lowering effect of albuterol for hyperkalemia in renal failure. Arch Intern Med 147:713-717, 1987
32. Montoliu J, Almirall J, Ponz E, Campistol J, Revert L: Treatment of hyperkalemia in renal failure with salbutamol inhalation. J Intern Med 228:35-37, 1990
33. Brown M, Brown D, Murphy M: Hypokalemia from beta-receptor stimulation by circulating epinephrine. N Engl J Med 309:1414-1419, 1983
34. Wong S, Maltz H: Albuterol for the treatment of hyperkalemia. Ann Pharmacother 33:103-106, 1999
35. DeFronzo R, Bia M, Birkhead G: Epinephrine and potassium homeostasis. Kidney Int 20:83-91, 1981
36. Allon M, Shanklin N: Adrenergic modulation of extrarenal potassium disposal in men with end-stage renal disease. Kidney Int 40:1103-1109, 1991
37. Wong C, Pavord I, Williams J, Britton J, Tattersfield A: Bronchodilator, cardiovascular, and hypokalemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet 336:1396-1399, 1990
38. Fenn W, Cobb D: The potassium equilibrium in muscle. J Gen Physiol 17:629-656, 1956
39. Burnell J, Villamil M, Uyeno B: The effect in humans of extracellular pH change on the relationship between serum potassium concentration and intracellular potassium. J Clin Invest 35:953-939, 1956
40. Schwarz K, Burton D, Lubash G: Severe acidosis and hyperpotassemia with sodium bicarbonate infusion. Circulation 19:215-220, 1959
41. Ahee P, Crowe A: The management of hyperkalemia in the emergency department. J Accident Emerg Med 17:188-191, 2000
42. Iqbal Z, Friedman E: Preferred therapy of hyperkalemia in renal insufficiency: survey of nephrology training program directors [letter]. N Engl J Med 320:60-61, 1989
43. Blumberg A, Weidmann P, Ferrari P: Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure. Kidney Int 41:369-374, 1992
44. Gutierrez R, Schlessinger F, Oster J, Rietberg B, Perez G: Effect of hypertonic versus isotonic sodium bicarbonate on plasma potassium concentration in patients with end-stage renal disease. Miner Electrolyte Metab 17:297-302, 1991
45. Scherr L, Ogden D, Mead A: Management of hyperkalemia with a cation-exchange resin. N Engl J Med 264:115-119, 1961
46. Lillemoe K, Romolo J, Hamilton S, Pennington L, Burdick J, Williams G: Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis. Surgery 101:267-272, 1987
47. Gertsmann B, Platt R: Use of sodium polystyrene sulfonate in sorbitol in the United States, 1985-1989. Am J Kidney Dis 18:619-620, 1991
48. Rashid A, Hamilton S: Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition. Am J Surg Pathol 21:60-69, 1997
49. Rogers F, Li S: Acute colonic necrosis associated with sodium polystyrene sulfonate (Kayexalate) enemas in a critically ill patient: case report and review of the literature. J Trauma 51:395-397, 2001
50. Dardik A, Moesinger R, Efron G, Barbul A, Harrision M: Acute abdomen with colonic necrosis induced by Kayexalate-sorbitol. South Med J 93:511-513, 2000
51. Gruy-Kapral C, Emmett M, Santa C, Porter J, Fordtran J, Fine K: Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal disease. J Am Soc Nephrol 9:1924-1930, 1998
52. Blumberg A, Roser H, Zehnder C, Muller-Brand J: Plasma potassium in patients with terminal renal failure during and after haemodialysis: relationship with dialytic potassium removal and total body potassium. Nephrol Dial Transplant 12:1629-1634, 1997
53. Hou S, McElroy P, Nootens J, Beach M: Safety and efficacy of low-potassium dialysate. Am J Kidney Dis 13:137-143, 1989
54. Flinn R, Merrill J, Welzant W: Treatment of the oliguric patient with a new sodium-exchange resin and sorbitol, a preliminary report. N Engl J Med 264:111-114, 1961
55. Emmett M: Non-dialytic treatment of acute hyperkalemia in the dialysis patient. Semin Dial 13:279-280, 2000
56. Mehta S, Hill N: Noninvasive ventilation. Am J Respir Crit Care Med 163:540-577, 2001
57. Delclaux C, L'Her E, Alberti C, Mancebo J, Abroug F: Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivered by a face mask. JAMA 284:2352-2360, 2000
58. Sharon A, Shpirer I, Kaluski E, Moshkovitz Y, Milovanov O, Polak R, Blatt A, Simovitz A, Shaham O, Faigenberg Z, Metzger M, Stav D, Yogev R, Golik A, Krakover R, Vered Z, Cotter G: High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema. J Am Coll Cardiol 36:832-837, 2000
59. Wood K, Lewis L, Von Harz B, Kollef M: The use of noninvasive positive pressure ventilation in the emergency department: results of a randomized clinical trial. Chest 113:1339-1346, 1998
60. Peter J, Moran J, Phillips-Hughes J, Warn D: Noninvasive ventilation in acute respiratory failure a meta-analysis update. Crit Care Med 30:555-562, 2002
61. International Consensus Conferences in Intensive Care Medicine: Noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med 163:283-291, 2001
62. Plant P, Owen J, Ellitt M: Early use of noninvasive positive pressure ventilation of COPD on general medicine wards. Lancet 355:1931-1935, 2000
63. Rusterholtz T, Kempf J, Berton C, Gayol S, Tournoud C, Zaehringer M, Jaeger A, Sauder P: Noninvasive pressure support ventilation (NIPSV) with face mask in patients with acute cardiogenic pulmonary edema (ACPE). Intensive Care Med 25:21-28, 1999
64. Lin M, Yang Y, Chiang H, Chang M, Chiang B, Cheitlin M: Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Chest 107:1379-1386, 1995
65. Masip J, Betbese A, Paez J, Vecilla F, Canizares R, Padro J, Paz M, de Otero J, Ballus J: Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary edema: a randomized trial. Lancet 356:2126-2132, 2000
66. Hsu H, Hickey R, Forbes A: Morphine decreases peripheral vascular resistance and increases capacitance in man. Anesthesiology 50:98-102, 1979
67. Pur-Shahriari A, Mills R, Hoppin F: Comparison of chronic and acute effects of morphine sulfate on cardiovascular function. Am J Cardiol 20:654, 1967
68. Timmis A, Rothman M, Henderson M, Geal P, Chamberlain: Haemodynamic effects of intravenous morphine in patients with acute myocardial infarction complicated by severe left ventricular failure. Br Med J 280:980-982, 1980
69. Vismara L, Leaman D, Zelis R: The effects of morphine on venous tone in patients with acute pulmonary edema. Circulation 54:335-337, 1976
70. Zelis R, Mansour E, Capone R, Mason D: The cardiovascular effects of morphine: the peripheral capacitance and resistance vessels in human subjects. J Clin Invest 54:1247-1258, 1974
71. Part 6: Advanced cardiovascular life support: Section 6: Pharmacology II. Agents to optimize cardiac output and blood pressure. Circulation: 102:I129-I135
72. Hoffman J, Reynold S: Comparison of furosemide in treatments of presumed pre-hospital pulmonary edema. Chest 92:583-593, 1987
73. Dikshit K, Vyden J, Forrester J: Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med 288:1087, 1973
74. Bourland W, Day D, Williamson H: The role of the kidney in the early nondiuretic action of furosemide to reduce elevated left atrial pressure in the hypervolemic dog. J Pharmacol Exp Ther 202:221-229, 1977
75. Johnston G, Hiatt W, Nies A, Payne NA, Murphy RC, Gerber JG: Factors modifying the early nondiuretic vascular effects of furosemide in man. The possible role of renal prostaglandins. Circ Res 53:630-635, 1983
76. Pickkers P, Dormans T, Russel F, Hughes A, Thien T, Schaper N, Smits P: Direct vascular effects of furosemide in humans. Circulation 96(suppl):1847-1852, 1997
77. Anderson C, Shahvari G, Zimmerman J: The treatment of pulmonary edema in absence of renal function: a role for sorbitol and furosemide. JAMA 241:1008-1010, 1979
78. Schmieder R, Messerli F, deCarvalho J, Husserl F: Immediate hemodynamic response to furosemide in patients undergoing chronic hemodialysis. Am J Kidney Dis 9:55-59, 1987
79. Francis G, Siegel R, Goldsmith S, Olivari M, Levine B, Cohn J: Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Ann Intern Med 103:1-6, 1985
80. Harada K, Ohmori M, Fujimura A, Ohashi K: No evidence of a direct venodilatory effect of furosemide in healthy human subjects. J Clin Pharmacol 36:271-273, 1996
81. Sacchetti A, McCabe J, Torres M, Harris R: ED management of acute congestive heart failure in renal dialysis patients. Am J Emerg Med 11:644-647, 1993
82. Sacchetti A, Ramoska E, Moakes M, McDermott P, Moyer V: Effect of ED management on ICU use in acute pulmonary edema. Am J Emerg Med 17:571-574, 1999
83. Cohn J, Burke L: Nitroprusside. Ann Intern Med 54:335-337, 1979